ECM
ALXN

Endex Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Endex Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$265K Hold
1,995
– – 0.25% 109
2013
Q3 		$232K Hold
1,995
– – 0.24% 110
2013
Q2 		$184K Buy
+1,995
New +$192K 0.2% 135

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Endex Capital Management's ALXN Position: Q4 2013 in Review

Endex Capital Management held its Alexion Pharmaceuticals (ALXN) position steady in Q4 2013 at 1,995 shares worth $265K. The position accounts for 0.25% of the portfolio, ranked #109.

Endex Capital Management first reported a position in ALXN in Q2 2013 and has held it in 3 quarters since. 463 funds tracked by Wall St. Rank hold ALXN as of Q4 2013.

  • Endex Capital Management held 1,995 shares of Alexion Pharmaceuticals worth $265K as of Q4 2013.
  • Endex Capital Management left its Alexion Pharmaceuticals share count unchanged in Q4 2013.
  • Alexion Pharmaceuticals made up 0.25% of Endex Capital Management's portfolio in Q4 2013, its #109 holding.
  • Endex Capital Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
  • 463 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2013.

Based on Endex Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.